Understanding Your Mounjaro KwikPen: Can You Use the 5th Dose?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The Mounjaro KwikPen contains 2.4 mL of tirzepatide solution, which is engineered to dispense exactly four doses of 0.5 mL each when used as directed. Many patients ask whether leftover medication remains after the fourth injection, and whether attempting to extract it is safe or effective. Understanding your medication delivery device helps you make informed decisions about your treatment plan.

How the Mounjaro KwikPen Delivers Medication

The Mounjaro KwikPen is a pre-filled, single-use injection pen that holds 2.4 mL of tirzepatide solution at a concentration of 100 mg/mL. The pen's mechanical design uses a precisely calibrated plunger and needle system to release 0.5 mL increments with each injection. After you complete four doses, the pen's internal stop mechanism prevents further medication from being dispensed, even if you attempt additional clicks or twists.

This safety feature exists for multiple reasons: maintaining sterility after the needle retracts, preventing medication degradation, and ensuring you do not accidentally inject an unmeasured or partial dose. The pen's design is validated through manufacturing standards that account for dead-space volume—the small amount of liquid that remains in the needle and chamber after dispensing. Attempting to force additional doses risks damaging the pen's internal mechanism and potentially drawing air into the syringe.

Is There Really a Fifth Dose in Your Pen?

Residual medication does technically remain in the Mounjaro KwikPen after four doses, but the amount is minimal and not intended for patient use. The pen contains approximately 0.4 mL of unused solution after the fourth injection, which accounts for dead space in the needle hub and delivery chamber. This remainder is too small to constitute a full therapeutic dose and cannot be reliably accessed without compromising the pen's sterility or needle integrity.

Some online discussions suggest that patients can manually extract this remainder using a separate syringe, but pharmaceutical manufacturers and healthcare providers do not recommend this practice. Accessing the internal reservoir violates the pen's sterile design, introduces contamination risk, and may result in an incomplete or inaccurate dose. If you are concerned about medication wastage or cost, discussing alternative tirzepatide delivery options with your healthcare provider is a more practical and safe approach.

Tirzepatide Injection Options Beyond the Mounjaro Pen

If you are using Mounjaro and concerned about cost or pen design limitations, compounded tirzepatide injection offers a flexible alternative. PlexusDx provides compounded tirzepatide injection prepared by licensed 503A compounding pharmacies at a flat rate of $289 per month, regardless of your current dose level—your dose may need to go up, but your price will not. Compounded tirzepatide is available in vials that you can pair with standard insulin syringes, giving you control over exact dosing and reducing concerns about medication waste.

Compounded formulations allow your healthcare provider to customize your starting dose, titration schedule, and maintenance level based on your individual response and health status. Unlike pre-filled pens with fixed dose increments, vial-based therapy provides flexibility if you need a dose adjustment that falls outside standard pen markings. PlexusDx compounds serve all 50 states without requiring insurance, and your medication is HSA/FSA eligible.

Precision Genetic Testing to Optimize Your Tirzepatide Response

Your genetic makeup influences how effectively tirzepatide works in your body and which dose may be optimal for your weight loss goals. PlexusDx offers the Precision Peptide Genetic Test—a peptide-pathway genetic assessment that analyzes 14 metabolic pathways, 49 peptide-related genes, and 150+ genetic insights. Key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 affect your appetite regulation, metabolic rate, and GLP-1 receptor sensitivity.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I safely use a fifth dose from my Mounjaro KwikPen?

No. The Mounjaro KwikPen is designed to deliver exactly four doses, and attempting to extract a fifth dose risks compromising sterility and medication accuracy. The remaining solution cannot be reliably accessed and is too small to constitute a therapeutic dose. If cost is your concern, PlexusDx compounded tirzepatide injection at $289/mo (or $249/mo on the 6-month plan) offers a more affordable and flexible alternative.

What is dead-space volume, and how much medication is it?

Dead-space volume refers to the small amount of liquid that remains in the injection needle and delivery chamber after dispensing. In the Mounjaro KwikPen, approximately 0.4 mL of solution occupies dead space after your fourth dose—roughly 40 mg of tirzepatide. This amount is built into the pen's design and cannot be safely or reliably extracted by patients.

How much does PlexusDx compounded tirzepatide injection cost?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) on the entry commitment tier, with pricing remaining flat regardless of your current dose—your dose may go up, but your price will not. The medication is prepared by licensed 503A compounding pharmacies, is available in all 50 states without insurance, and is HSA/FSA eligible.

What are the risks of manually extracting medication from the pen?

Manually extracting medication introduces bacteria and contaminants into a sterile system, damages the pen's internal mechanism, and may result in an incomplete or inaccurate dose. Healthcare providers do not recommend this practice because it violates pharmaceutical safety standards and increases infection risk. A compounded vial-based approach provides safe, flexible dosing without these risks.

How can the Precision Peptide Genetic Test improve my tirzepatide results?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.